Clinical trial
Hypertension in Breast Cancer Patients Receiving Bevacizumab
NCT00674011
Study timeline
Study start (unknown)2008-01-01Date precision: month
Registry last updated2014-05-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
BevacizumabDRUG · verified · RxNorm: bevacizumab
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
Brigham and Women's Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00674011 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.